Eiger Biopharmaceuticals Inc (EIGR) Peer Comparison

$2.27

$-- (--%)

As on 10-May-2024 09:30EDT

Market cap

$3 Mln

Revenue (TTM)

$16 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Market cap ($ Mln)	3	1
Revenue ($ Mln)	16	133
Net Profit ($ Mln)	-74.96	-453.79
Net Margin (%)	-436.59	-340.28
RoE (%)	-367.00	--
Price to Earnings	--	--
Price-To-Book	0.87	0.05

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Operating Revenue	15.77	117.63
Cost of Revenue	0.02	46.05
Gross Profit	15.75	71.59
Operating Expenses	87.54	94.85
Operating Profit (EBIT)	-71.79	-23.26
Other Income	--	--
Profit before Tax	-74.96	-296.02
Provision for Tax	0.01	-43.17
Profit after Tax (Net Income)	-74.96	-252.85
Minority Interest	--	--
Consolidated Profit	--	--

Liabilities ($ Mln)

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Shareholder's Funds	-14.46	-157.96
Minority Interest	--	--
Non-Current Liabilities	0.00	47.93
Current Liabilities	53.28	227.77
Total Liabilities	38.83	117.75

Assets ($ Mln)

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Non-Current Assets	0.99	42.95
Current Assets	37.84	74.79
Total Assets	38.83	117.75
Total Debt*	41.20	190.90
Net Current Assets	-15.45	-152.98

Cashflow ($ Mln)

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Cash From Operating Activities	-74.55	-13.98
Cash Flow from Investing Activities	--	--
Cash from Financing Activities	0.04	--
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
ROCE (%)	-122.63	-168.86
ROE (%)	-367.00	786.07
ROA (%)	-94.31	-98.51
EBIT Margin (%)	--	--
Net Margin (%)	-475.26	-214.95
Cash Profit Margin (%)	--	--

Growth Ratios

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Revenue Growth (%)	0.17	-0.01
EBIT Growth (%)	--	--
Net Profit Growth (%)	22.54	-283.60
EPS Growth (%)	0.23	-5.75
Book Value Growth (%)	--	--

Valuation Ratios

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Price / Earnings	0.00	-0.07
Price / Book Value	-0.02	-0.12
Dividend Yield (%)	--	--
EV/EBITDA	-0.23	21.34
Market Cap ($ Cr)	--	--

Solvency Ratios

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Debt to Equity	-2.85	-1.21
Short term debt to equity ratio	-2.85	-1.19
Current Ratio	0.71	0.33
Quick Ratio	0.68	0.26
Interest Coverage	-12.71	-0.74

Operating Efficiency Ratios

	Eiger Biopharmaceuticals Inc (EIGR)	Acorda Therapeutics (ACOR)
Debtors to sales (%)	10.66	14.71
Asset Turnover	0.20	0.46
Receivable days	39.73	48.38
Inventory Days	33,549.73	114.65
Payable days	84,387.97	93.04
Cash Conversion Cycle	-50,798.51	69.99

Annual
Quarterly